Project Grant R21AG086859
Award Date
8/1/24
Completion Date
7/31/26
Dollars Obligated
$443K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
College Park, MD 20742, USA
Similar Awards
The National Institute on Aging awarded a $480,536 Project Grant under the Aging Research program (CFDA 93.866) to The Jackson Laboratory to fund research aimed at improving treatment for Alzheimer's disease and related dementias (ADRD). The project will assess whether manipulating the angiopoietin/tie2 (ANG/TIE2) signaling pathway can preserve blood-brain barrier (BBB) integrity and prevent cerebrovascular dysfunction, which are major contributors to many ADRDs. The research approach involves...
This $654,238 Project Grant award from the National Institute on Aging (NIA) under CFDA Program 93.866 - Aging Research supports research to investigate the role of senescent cells in brain aging and the development of Alzheimer's disease and related dementias (ADRD). The project aims to generate high-resolution spatial omics data from ADRD brains and mouse models to identify molecular changes in the microenvironment of senescent neurons compared to healthy neurons. The work will be conducted by...
The National Institute on Aging (NIA) awarded a $828,534 Cooperative Agreement under the Aging Research federal grant program (CFDA 93.866) to the University of Massachusetts Medical School (UMass Medical) to conduct a molecular dissection of the neuronal-adaptive immune-genomic axis. The goal is to identify novel integrative factors contributing to Alzheimer's disease (AD) pathogenesis or to the protection of brain neurons in the aging process. The project will apply large-scale, innovative,...
This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $622,000 in funding to the University of Maryland, Baltimore to investigate the role of mitochondrial complex I deficiency in the development of Alzheimer's disease and dementia. The key objectives are to: 1) Determine the effects of complex I deficiency on humanized amyloid beta proteinopathy, a hallmark of Alzheimer's disease, and 2) Assess the susceptibility of complex I-deficient...
The National Institute on Aging (NIA) awarded a $125,896 Project Grant under the Aging Research program (CFDA 93.866) to The Washington University in St. Louis to conduct research on Alzheimer's disease (AD) risk and resilience pathways. The project aims to perform deep molecular characterization of AD genetic risk factors and protective mechanisms using state-of-the-art single-cell multi-omic analyses of healthy and AD human brain tissue, as well as transgenic AD mouse models. Key objectives...
This federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $2,173,794 to The General Hospital Corporation (Massachusetts General Hospital) to conduct research on enhancing brain resilience to Alzheimer's disease by targeting adult hippocampal neurogenesis. The project aims to explore the mechanisms by which adult hippocampal neurogenesis cooperates with brain-derived neurotrophic factor (BDNF) to potentially slow cognitive decline in...
This federal Project Grant award of $614,424 from the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of Washington aims to investigate the role of microglia, the brain's immune cells, in the early progression of Alzheimer's disease (AD). The key products and services to be delivered under this 2-year award include: Applying novel explainable AI techniques and deep learning methods to single-cell brain data to better define subtle microglial changes and AD-specific...
The National Institutes of Health National Institute on Aging awarded The Medical University of South Carolina $4,507,228 under the Aging Research federal grant program (CFDA 93.866) to study neuroprotective mechanisms of Bach1-derepression in Alzheimer's disease from August 1, 2022 to July 31, 2025. The Medical University will conduct rigorous evaluation to validate Bach1 inhibition as a novel therapeutic strategy for Alzheimer's disease pathogenesis and identify new targets for intervention....
This Project Grant award from the National Institute on Aging's Aging Research federal grant program (CFDA 93.866) provides $871,419 to the University of Washington to conduct research on the role of microglia, the brain's immune cells, in the pathogenesis of Alzheimer's disease. The research aims to characterize molecular profiles and spatial organization of microglia across the adult age spectrum, both with and without Alzheimer's disease, through single-nucleus RNA sequencing of over 5,000...
This $200,323 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will support research by the University of South Florida to investigate the aggregation of amyloid-beta (Aβ) peptides during metabolic stress and spreading depolarization events in the brain. The project will utilize multiscale modeling, high-resolution microscopy, antibody staining, and paralysis phenotype testing in C. elegans to determine how physiochemical changes...